Researchers will improve techniques for monitoring anticoagulant therapy and preventing blood clot complications in dogs with immune-mediated hemolytic anemia.

Researchers will evaluate a novel drug as a potential new treatment for immunemediated hemolytic anemia, a serious and fatal blood disorder in dogs.